Intervention Review

Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease

  1. Audra Stewart2,
  2. Luc P Brion1,*

Editorial Group: Cochrane Neonatal Group

Published Online: 7 SEP 2011

Assessed as up-to-date: 3 JAN 2011

DOI: 10.1002/14651858.CD001453.pub2


How to Cite

Stewart A, Brion LP. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD001453. DOI: 10.1002/14651858.CD001453.pub2.

Author Information

  1. 1

    University of Texas Southwestern at Dallas, Division of Neonatal-Perinatal Medicine, Dallas, Texas, USA

  2. 2

    University of Texas Southwestern Medical Center at Dallas, Neonatal-Perinatal Medicine, Dallas, Texas, USA

*Luc P Brion, Division of Neonatal-Perinatal Medicine, University of Texas Southwestern at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas, 75390-9063, USA. Luc.Brion@UTSouthwestern.edu.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 SEP 2011

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Anjali Iyengar, Jonathan M. Davis, Drug therapy for the prevention and treatment of bronchopulmonary dysplasia, Frontiers in Pharmacology, 2015, 6,

    CrossRef

  2. 2
    Anne Greenough, Anoop Pahuja, Updates on Functional Characterization of Bronchopulmonary Dysplasia – The Contribution of Lung Function Testing, Frontiers in Medicine, 2015, 2,

    CrossRef

  3. 3
    Jeffrey L. Segar, Neonatal Diuretic Therapy: Furosemide, Thiazides, and Spironolactone, Clinics in Perinatology, 2012, 39, 1, 209

    CrossRef